During development, axon growth rates are precisely regulated to provide temporal control over pathfinding 1,2 . The precise temporal regulation of axonal growth is a key step in the formation of functional synapses and the proper patterning of the nervous system. The rate of axonal elongation is increased by factors such as netrin-1 and nerve growth factor (NGF), which stimulate axon outgrowth using incompletely defined pathways. To clarify the mechanism of netrin-1-and NGF-stimulated axon growth, we explored the role of local protein translation. We found that intra-axonal protein translation is required for stimulated, but not basal, axon outgrowth. To identify the mechanism of translation-dependent outgrowth, we examined the PAR complex, a cytoskeleton regulator 3 . We found that the PAR complex, like local translation, is required for stimulated, but not basal, outgrowth. Par3 mRNA is localized to developing axons, and NGF and netrin-1 trigger its local translation. Selective ablation of Par3 mRNA from axons abolishes the outgrowth-promoting effect of NGF. These results identify a new role for local translation and the PAR complex in axonal outgrowth.
An important aspect of axon pathfinding is the regulation of the rate of axonal elongation. At some stages in axon pathfinding, axons show periods of reduced or absent growth, whereas at other stages, growth is markedly stimulated 1, 2, 4 . In animals harbouring a genomic deletion of genes encoding either netrin-1 or NGF, signalling proteins that promote rapid axonal outgrowth of commissural and sensory axons, respectively, these axons continue to grow, but at a markedly reduced rate 5, 6 . These findings suggest the existence of a basal independent axon growth rate and an NGF-or netrin-1-induced growth rate that is required to promote axonal elongation during development.
A distinguishing feature of developing axons, in contrast to mature axons, is their ability to translate proteins locally 7, 8 , suggesting that local protein translation might have roles during axon guidance. Indeed, growth cone turning responses elicited by semaphorin-3A and netrin-1 are blocked by selective axonal application of translation inhibitors 9, 10 . Furthermore, axonally localized β-actin mRNA is translated in Xenopus laevis retinal growth cones in a manner consistent with a role in netrin-1-induced growth cone turning 11 . Additionally, NGF and netrin-1 induce a rapid increase in 4E-BP1 (initiation factor 4E binding protein) phosphorylation within growth cones, a marker of the induction of intra-axonal protein translation 9, 12 . However, the repulsive turning effect of L-α-lysophosphatidic acid is independent of local protein synthesis 9 , and local protein synthesis is not required for axon growth in rat sympathetic neurons 13 . Therefore, intra-axonal protein synthesis is used by certain guidance cues and is a component of only selective aspects of growth cone function.
To determine the involvement of local protein synthesis in axonal growth, we cultured rat embryonic dorsal root ganglia (DRG) in compartmentalized microfluidic chambers 14 (Fig. 1a) , which allowed treatments to be selectively applied to axons 14 . The axons were kept for 24 h at an NGF concentration (5 ng ml -1 ) that does not induce axon outgrowth ( Supplementary Information, Fig. S1a ). Consistent with previous reports 15 , application of 100 ng ml -1 NGF for 1 h to the axonal compartment resulted in a 1.37 ± 0.12-fold increase in axonal growth relative to the vehicle (Fig. 1b ). Selective axonal application of two mechanistically distinct translation inhibitors, cycloheximide and rapamycin, did not significantly affect basal axonal growth rates ( Fig. 1b) , as has been shown previously for sympathetic neurons 13 . However, axonal application of cycloheximide or rapamycin completely inhibited NGF-stimulated axonal outgrowth ( Fig. 1b) , indicating that there are two modes of axonal elongation, translation-independent basal outgrowth and stimulated outgrowth, which uses local protein synthesis.
To identify transcripts whose translation is required for axon outgrowth, we considered mRNAs that encode signalling proteins known to be present in growth cones and which may control stimulated, but not basal, axon outgrowth. The PAR complex has been found to be highly enriched in the growth cones of nascent axons of hippocampal neurons 16 . It comprises the evolutionarily conserved proteins PAR3, PAR6 and an atypical PKC, such as aPKCζ or aPKCλ 3 , and functions in neurons to specify the axon from neurites during early neural development 16 . Although the PAR complex has been linked to membrane polarization and trafficking and has not been shown to affect axonal outgrowth, it can activate several signalling pathways that control cytoskeleton dynamics 3 . Interestingly, both NGF and netrin-1 promote the accumulation of active GTP-bound cdc42 (ref. 17) , which can recruit and activate the PAR complex 18 .
Consistent with previous studies 16 , we found PAR3, PAR6 and aPKCζ localized to the tips of the presumptive axon in cultured rat hippocampal neurons at embryonic day 18 (E18), day in vitro 1 (DIV1; Supplementary  Information, Fig. S2a ). At times when axon specification was completed, we found each of the PAR complex proteins still present in growth cones and axons of DIV5 DRG and DSC (dorsal spinal commissural) neurons and DIV9 hippocampal neurons ( Fig. 2a, b ; Supplementary Information,  Fig. S2b ). The specificity of immunofluorescence staining for PAR3 and PAR6 was confirmed by the lack of staining in dissociated DRG neurons transfected with Par3 or Par6 short interefering RNA (siRNA; Fig. 2c-f ). Together, these data indicate that the PAR complex is present in axons at the time when they are responsive to NGF and netrin-1.
To investigate the role of the PAR complex in developing axons, we examined the effect of siRNA-mediated knockdown of Par3 and Par6 on commissural axons in spinal cord explants. During the development of the spinal cord, axons of commissural neurons in the dorsal neural tube grow towards the floor plate at the ventral midline. Growth towards the midline is caused by two long-range chemoattractants secreted by the floor plate, netrin-1 (refs 5, 19, 20) and sonic hedgehog 21 . To visualize the length and direction of commissural axon projections in the developing spinal cord, we electroporated E11 rat spinal cord segments with siRNA and a GFP-expression plasmid, which results in selective labelling of DSC neurons (Fig. 3a) 22 . In untransfected or control siRNA-transfected spinal cord explants, most axons reached and crossed the midline two days after electroporation (Fig. 3b , c, f). In explants transfected with Par3 or Par6 siRNAs, the axons grew markedly shorter ( Fig. 3d-f ) but without a change in direction ( Fig. 3g, h) . The specificity of the siRNA-mediated knockdown was established by rescue with an siRNA-resistant Cherry-Par3 transcript (Supplementary Information, Fig. S3 ). Notably, the phenotype of stunted axons with preserved directionality is nearly identical to that observed in the embryonic spinal cord of mice harbouring genomic deletions in the genes for netrin-1 and its receptor, DCC 5, 23 . Together, these results indicate that PAR3 and PAR6 are required for the growth of axons towards the spinal midline.
To further explore the possibility that the PAR complex might mediate the axon outgrowth effects of NGF and netrin-1, we examined the effects of interfering with complex formation on basal and stimulated axonal outgrowth. Embryonic DRG neurons require NGF for survival, and were therefore cultured in media containing a minimal concentration of NGF (5 ng ml -1 ) for 24 h, which results in basal levels of axonal growth ( Supplementary Information, Fig. S1a ) 24 . Application of 100 ng ml -1 NGF resulted in a 1.63 ± 0.19-fold increase in axonal outgrowth ( Fig. 3i, k) . Similarly, axons of cultured DSC neurons showed a basal axonal growth rate in the absence of netrin-1 that was increased 1.66 ± 0.14-fold on application of netrin-1 (75 ng ml -1 ; Fig. 3j ,l), consistent with previously described effects of netrin-1 on these neurons 25 .
To test the role of the PAR complex, the interactions between PAR3, PAR6 and aPKC, as well as aPKCζ activity, were disrupted by overexpressing well-characterized fragments that interfere with complex formation 26, 27 (see Methods). Expression of each fragment, or pharmacological inhibition of aPKCζ with a pseudosubstrate inhibitor, did not decrease basal axonal growth rates ( Fig. 3i, j) . However, each treatment inhibited, or even reversed, the growth-promoting effect of netrin-1 or NGF ( Fig. 3k, l) . These data indicate that complex formation between PAR3, PAR6, and aPKC and aPKCζ activity are required specifically for the axon outgrowth-promoting effects of netrin-1 and NGF, but not for axon growth under non-stimulated conditions.
The finding that the PAR complex is required for netrin-1-and NGFstimulated axonal outgrowth, but not basal outgrowth, is reminiscent of the requirement for local translation in stimulated, but not basal, axon outgrowth ( Fig. 1b ). This similarity prompted us to examine whether mRNAs encoding PAR-complex proteins were present in axons. A fluorescent in situ hybridization screen using riboprobes directed against mRNAs coding for constituents of the PAR complex revealed significant levels of Par3, but not Par6 or aPkcζ, transcripts in the axons of DIV4 DRG and DSC neurons ( Fig. 4a -c). The Par3 signal seemed granular and dispersed, as has been described for other axonal mRNAs 28, 29 , and had an intensity similar to that of RhoA, an axonally localized transcript 12, 28, 29 (Fig. 4b, c ). To confirm the axonal localization of Par3 mRNA, we performed reverse transcription-PCR (RT-PCR) experiments on pure axonal preparations of DRG neurons cultured in microfluidic chambers 14, 30 ( Supplementary Information, Fig. S4a ). RT-PCR using two distinct primer pairs resulted in amplification of Par3 and β-actin transcripts from axon preparations, whereas RT-PCR signals for all three isoforms of Par6 and aPkcζ were absent ( Fig. 4d ; Supplementary  Information, Fig. S4 ). The purity of the axonal mRNA preparation was confirmed by the absence of a signal for the cell body-restricted γ-actin mRNA ( Fig. 4d ; Supplementary Information, Fig. S4 ). Together, the results from these two approaches indicate that developing axons contain Par3 mRNA, but not other transcripts encoding PAR complex components. The presence of Par3 mRNA in axons raises the possibility that the level of PAR3 protein in axons is regulated by local translation of its transcript. To differentiate between PAR3 protein that is synthesized in the cell body and subsequently trafficked to axons from PAR3 protein synthesized directly within axons, DRG explant axons were severed from their cell bodies. Isolated axons prepared in this manner continue to grow and respond to guidance cues for at least 4 h (ref. 9, 29) . To test the effect of NGF on PAR3 levels in axons, DRG explants were cultured in a low concentration of NGF (5 ng ml -1 ) for 24 h. Axons were then severed and treated with a low or high (100 ng ml -1 ) concentration of NGF in the absence or presence of cycloheximide for 1 h before being immunolabelled to quantify PAR3 protein levels ( Fig. 4e , f). In axons treated for 1 h with a low concentration of NGF, PAR3 levels were low and unaffected by cycloheximide treatment. However, severed axons exposed to high NGF levels showed a significant increase in PAR3 levels that could be totally blocked by cycloheximide ( Fig. 4f ).
To further examine the NGF-dependent increase of PAR3 levels in axons, we used a previously described reporter assay for axonal mRNA translation in which destabilized, membrane-anchored EGFP (enhanced green fluorescent protein) is expressed from an mRNA containing the 3UTR of the axonal mRNA 29, 31 (see Methods). The appearance of puncta along axons thus indicates local translation events mediated by cis-acting elements in the 3UTR. Reporter mRNAs containing the 3UTR of Par3 or, as a control, the 3UTR of histone H1f0 mRNA, were detected by FISH at equal levels in the cell bodies of transduced DRG neurons; however, only the reporter mRNA containing the 3UTR of Par3 was found in axons and growth cones ( Supplementary Information, Fig. S5a ). In DRG and DSC neurons expressing the Par3 reporter, very low levels of fluorescence were observed in unstimulated and cycloheximide-treated axons ( Fig. 4g ). However, treatment of these cultures with NGF or netrin-1 resulted in puncta throughout the axons and within growth cones ( Fig. 4g ; Supplementary Information, Fig. S5d , e, g). In contrast, axons expressing the control H1f0 reporter showed no fluorescence in axons under any condition (Supplementary Information, Fig. S5c , d, f, g). Together with the data on endogenous Par3 translation in severed axons, these results indicate that netrin-1 and NGF regulate axonal PAR3 levels through the local translation of Par3 mRNA.
To determine the role of intra-axonal translation of Par3 mRNA in axon outgrowth, we used a recently described approach to selectively knockdown specific mRNAs from axons without affecting the cell body mRNA pool 28 . To generate neurons lacking Par3 mRNA from axons, E14 DRG neurons were grown in microfluidic chambers in order to fluidically isolate cell bodies and axons. The axonal compartment was selectively perfused with either of two Par3-specific siRNAs and transfection reagent 28 . Axonal siRNA transfection resulted in knockdown of Par3 mRNA in axons without affecting Par3 mRNA in the cell bodies ( Fig. 5a, b ). In these axons, the NGF-induced increase in PAR3 was prevented, but PAR6 levels were unaffected ( Fig. 5e ; Supplementary Information, Fig. S6a -c), providing further evidence that local translation of Par3 is required for NGF-induced axon outgrowth. Furthermore, in axons depleted of Par3, NGF-induced outgrowth was completely abolished, whereas it was unaffected in axons transfected with control siRNA (Fig. 5c, d) .
A potential effector pathway of cdc42 and PAR6/aPKCζ is GSK3β (ref. 32 ). Phosphorylation of GSK3β at Ser 9 leads to its inhibition, thereby inducing the binding of APC (adenomatous polyposis coli) protein to the plus ends of microtubules 32 . Consistent with previous studies 15 , selective Par3 application of NGF to axons leads to a significant increase in GSK3β phosphorylation ( Supplementary Information, Fig. S6d, e ). This effect is greatly reduced by axonal Par3 mRNA knockdown, indicating that locally translated PAR3 regulates GSK3β in response to NGF stimulation. Together, these data identify a requirement for the axonal pool of Par3 mRNA in NGF-induced axonal outgrowth. The PAR complex regulates numerous signalling effectors besides GSK3β, including STEF/Tiam1 (ref. 33 ) and Smurf1 (ref. 34) . STEF/ Tiam1 are Rac-specific guanine nucleotide-exchange factors involved in neurite formation 33 , and Smurf1 is an E3-ubiquitin ligase that targets RhoA for degradation and promotes the formation of actin-rich filopodia-like protrusions in several cell types 34 . Therefore, the PAR complex may have a central role in axonal outgrowth by coordinating NGF and netrin-1 signalling with diverse pathways that control actin and microtubule dynamics ( Supplementary Information, Fig. S7 ).
Previous studies linked the PAR complex to neuronal polarization, the process by which dendrites and axons are specified from the neurites 16 . Our findings add the regulation of axonal outgrowth to the known functions of the PAR complex. Similar to the requirement for local translation, the PAR complex is required for stimulated, but not basal, outgrowth. We found that axons contain Par3 mRNA, and local PAR3 synthesis is part of the translation dependence of stimulated axonal outgrowth. Several mRNAs have been found previously to be present and translated in axons 35 ; however, in very few cases has a functional role been identified for them. Using neurons that are selectively depleted of axonal Par3 mRNA, we found that axonal Par3 mRNA is not required for basal outgrowth, but is required for axonal outgrowth elicited by NGF and netrin-1. This study identifies a new mechanism regulating axonal elongation, in which factors such as NGF and netrin-1 increase the synthesis and axonal levels of PAR3, triggering a switch to a rapid axonal growth mode.
Our study provides evidence for a new mechanism for the regulation of the PAR complex. Activation of PAR-complex signalling is thought to be regulated by selective recruitment to specific membrane domains 3 . Here we find that local translation of Par3 mRNA regulates the levels of PAR3 protein in growth cones. This unexpected mechanism of PAR complex regulation may be a recurrent feature of PAR complex signalling in diverse physiological processes and cell types.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology/.
Cell culture and outgrowth assays. All reagents were from Invitrogen, unless otherwise indicated. E14 rat DRG and DSC explants and dissociated neurons were cultured as described previously 25, 29 . E14 rat DRG explants were plated in 24-well culture dishes or on glass cover-slips pre-coated with 33 μg ml -1 poly-dlysine and 1 μg ml -1 fibronectin (ICN Biomedicals). DRG explants were cultured in neurobasal medium supplemented with 1 × B-27, 100 ng ml -1 NGF, 2 mM glutamine, 20 μM 5-fluorodeoxyuridine (ICN Biomedicals), 100 IU penicillin and 100 μg ml -1 streptomycin. DSC explants were cultured in minimum essential medium supplemented with 1 × N2, 2% fetal bovine serum, 2 mM glutamine, 100 IU penicillin and 100 μg ml -1 streptomycin. E14 dissociated DSC neurons were prepared by incubating dorsal spinal cord tissue for 20 min in 1 × Hank's balanced salt solution at 37 °C, before tritrating through a fire polished Pasteur pipette. To confirm the specificity of the phosphoGSK3β Ser 9 antibody, HEK293 cells were incubated for 45 min with the serine/threonine phosphatase inhibitor calyculin A 36 (100 nM; Cell Signaling) and treated after fixation for 30 min at 30 °C with λ protein phosphatase 37 (8,000 U ml -1 ; New England Biolabs). For axon outgrowth experiments, 24 h before the assay, the medium used for DRG cultures was exchanged to growth medium containing 5 ng ml -1 NGF. This concentration is sufficient to sustain cell survival but does not induce axon outgrowth ( Supplementary Information, Fig. S1a ). 100 ng ml -1 NGF or 75 ng ml -1 netrin-1 were both applied to DRG or DSC explants, respectively, and phase-contrast images were taken of the same optical fields with a Nikon TE-2000-E microscope equipped with a CoolSnap HQ 2 CCD camera at 0 min and 60 min for DRG experiments and at 0 min and 180 min for DSC experiments. We found previously that this netrin-1 concentration is the optimal dose for filopodia formation in DSC axons 25 . One-way ANOVA with post-tests was used for the comparison of three or more groups, and unpaired, two-tailed student's t-test was used for the comparison of two groups. Error bars represent mean ± s.e.m. from a minimum of three independent experiments.
Compartmentalized culture in microfluidic chambers. To apply NGF, translation inhibitors, or siRNA, specifically to distal axons and growth cones without affecting the cell bodies, E14-dissociated DRG neurons were grown in microfluidic chambers with 450-μm-long microgrooves (Xona Microfluidics) 14 . These chambers allow fluidic isolation of the axonal compartment from the cell body compartment 14 . The microfluidic chambers were coated with 100 μg ml -1 poly-L-lysine (Trevigen). The growth medium was completely exchanged after 48 h. siRNA transfection in the axonal compartment was performed on DIV3 and outgrowth assays and FISH (fluorescence in situ hybridization) was done on DIV4.
Immunofluorescence. Neurons grown on 12-mm-diameter glass coverslips were fixed in 4% paraformaldehyde in cytoskeletal buffer (60 mM PIPES at pH 7.0, 27 mM HEPES, 10 mM EGTA and 4 mM MgSO 4 ) for 20 min at room temperature. The cover slips were washed three times in TBST (0.1% triton X-100 in TBS), blocked for 30 min in 3% bovine serum albumin (BSA) in TBST and labelled with primary antibodies in blocking solution. Antibodies used were against PAR3 (1:1,000; Millipore), PAR6 (1:1,000; ref. 18), cdc42 (1:250; Santa Cruz Biotechnology), aPKCζ (1:250; Santa Cruz Biotechnology); phosphoGSK3β (Ser 9; 1:250; Abcam), GSK3β (1:500; Thermo Fisher Scientific), GAP43 (1:2,000, Millipore) and tau-1 (1:1,000, Millipore). Alexa 488 and 568 conjugated secondary antibodies were used. Stacks of images were acquired and three-dimensional deconvolution was done with AutoDeblur X (Media Cybernetics). siRNA transfection. siRNA-mediated knockdown of Par3 mRNA was achieved by transfecting siRNA oligonucleotides using Genesilencer transfection reagent (Genlantis) as described previously 25, 28 . Experiments were performed 24 h after siRNA transfection. The siRNAs used to knockdown Par3 and Par6 mRNA were: Par3 (Genebank accession number NM_031235) siR-NAs 1 + 2 5-UCGGCCUUAUCAAACCACAAGUGAA-3 and 5-GGG UCUGAAGAAAUCCAGCUCUUUA-3; Par6 (AY682587) siRNAs 1 + 2 5-GCACUUCAGUGAGAGGCUUUCAGGA-3 and 5-CAACU CUCUA-CAGAGGCGCAAGAAA -3; control siRNA (siControl #2, Dharmacon).
Electroporation of embryonic spinal cords.
Electroporation of spinal cords explants was performed as described previously 22 , with minor modifications. Vertebral columns were dissected from rat E11 embryos and incubated with orbital shaking in 1 mg ml -1 dispase in L15 for 20 min at room temperature to dissociate spinal cords from surrounding tissue. Spinal cord explants were placed into 10 μl PBS containing 5 μg pUB-GFP, a plasmid that expresses GFP under the control of a ubiquitin promoter, and 0.1 nmol siRNA, and electroporated with needle-style electrodes (BTX-Havard Apparatus) using a square wave protocol (5 pulses of 50 msec, 20 V, 1 sec interval). For the electroporation, spinal cords were orientated with their dorsal side closest to the anode to preferentially target cell bodies in the dorsal root entry zone. Directly after electroporation, the spinal cord explants were embedded in a collagen matrix and cultured in 45% OptiMEM-I, 50% F12, 5% fetal bovine serum, 40 mM glucose, 2 mM glutamine, 100 IU penicillin and 100 μg ml -1 streptomycin 21 . Spinal cords were electroporated at a developmental stage (E11) at which commissural axons have formed and are growing towards, but have not yet reached, the midline 22 . Therefore, we can exclude the possibility that experimental treatments affect axon specification. Explants were electroporated with siRNA and a GFP-expressing plasmid, cultured for 48 h, removed from the collagen matrix, fixed in 4% paraformaldehyde in TBS and mounted on coverslips using ProLong Gold. For the quantification of commissural axon growth, lines parallel to the ventral border of the dorsal root entry zone were drawn in 50-μm intervals and the number of axons crossing these lines was determined along a 150-μm-long segment of the spinal cord.
Generation and transduction of Sindbis virus. A Sindbis virus vector containing
the P76S point mutation in the nsP2 protein leading to reduced neuronal cytotoxicity 29 and the helper plasmid DH-BB (S. Schlesinger) were used to generate Sindbis pseudovirions according to the manufacturer's instructions (Invitrogen). The pseudovirus particles were purified over a sucrose gradient, concentrated and titred using BHK-21 cells. For axonal overexpression of dominant-negative proteins, a modified viral vector was used containing an encephalomyocarditis virus internal ribosome entry site (IRES) 29 . This virus allows the overexpression of proteins directly off the viral genome in axons, without requiring cell body infection 12 .
Reporter experiments used the myr-dEGFP system 31 that involves expressing a transcript encoding destabilized, EGFP with a cellular half-life of 1 h, which enables dynamic changes in translational activity to be reflected by changes in fluorescence intensity 31 . Additionally, the reporter contains a myristoylation consensus sequence, resulting in a myristoylated, destabilized EGFP (myr-d1EGFP), which shows negligible diffusion in the plasma membrane 29, 31 . As a result of these two features, translation of the reporter leads to the appearance of fluorescent puncta, which remain localized near the site of translation. Colabelling with ribosomal markers identified these puncta as ribosome-enriched hotspots of translation 12, 31 . pSinRep5-myr-d1EGFP 3UTR PAR3 and pSinRep5-myr-d1EGFP 3UTR H1f0 contained the full length 3UTR of the rat Par3 mRNA (Genbank accession number NM_031235) or rat histone H1f0 mRNA (BC061842) fused to the viral 3 conserved sequence element.
Fluorescence in situ hybridization. Antisense riboprobes were transcribed in vitro from sense oligonucleotides using the MEGAshortscript in vitro transcription kit (Ambion) with digoxigenin-conjugated UTP (Roche). For the detection of each mRNA, a mix of five non-overlapping riboprobes was used. The riboprobes are matched in theit GC content. All sense oligonucleotides used to generate riboprobes were synthesized with a T7 promoter site (… RT-PCR. Isolation of pure axonal mRNA and RT-PCR was performed as described previously 30 . E14 DRG neurons (30,000-50,000) were grown in a tripartite microfluidic chamber, in which the distal axons are separated from the cell body compartment by an additional compartment ( Supplementary Information, Fig. S4a ). The use of these chambers essentially eliminates the possibility of neuronal or glial cell bodies migrating to the axonal side. On DIV5, chambers were inspected for the presence of cell bodies on the axonal sides to confirm complete partitioning of the cell bodies and axons. Pure distal axons and cell bodies were prepared by perfusing Trizol reagent in the corresponding compartment, and the RNA in the lysates was extracted using the Trizol protocol. The RNA was resuspended in 10 μl H 2 O. cDNA was transcribed using the SuperScript III First-Strand Synthesis SuperMix for qRT-PCR using oligo(dT) 20 primers and random hexamers in a 20 μl reaction using the entire RNA preparation. cDNAs were amplified using Platinum Taq DNA polymerase in 20 μl reactions: 4 U Taq polymerase, 2.5 μl cDNA, 1× DNA polymerase buffer, 0.2 μM primer, 0.2 mM dNTPs and 1.5 mM MgCl 2 . For the amplification, the following protocol was used: 94 °C for 2 min; 42 cycles: 94 °C for 30 s, 55 °C for 30 s, 72 °C for 17 s and 72 °C for 3 min. The following oligonucleotides were used as primers in the RT-PCR reaction: β-actin, 5-AGCCATGTACGTAGCCATCC-3 and 5-CTCTCAGCTGTGGTGGTGAA-3; γ-actin, 5-AACAGCAGACTTC-CAGGATTTCCC-3 and 5-TACACAATGACGTGTTGCTGGG-3; Par3 set 1, 5-ACC TG ACGA G GCCAAC ATTACTGA-3 and 5-TTC TC A GG CAC TTTA-GC AACCCAG-3; Par3 set 2, 5-GCCGGT CTA TCCAGTCCTTACTTT-3 and 5-TGGGAT GGCTCT CCTTCTGTTTGT-3; Par6A, 5-AA ATC GCCACCCTC-CCTGTTCTAA-3 and 5-TTA AT GT TC ACCAGG TTGAG CGGG-3; Par6B set 1, 5-CTGTCCTCAGTCATCAACTCTG-3 and 5-GCCTT TA TAC-AAGTC CGTTT-3; Par6C set 1, 5-CATCATTCCTACAACCTTA TTCT-3 and 5-TTA CA C G AACTGGTTAAA-3; Par6B set 2, 5-GTCCTC AGT C AT CAAC-TCTGTC-3 and 5-GCCTTTATACAAGTCCGTTT-3; Par6C set 2, 5-TCA-TCATTCCTACAACCTTATTC-3 and 5-TTACA CGAA CTG GT T AAA-3; aPkcζ, 5-AGTTAGC GTGTAATGCCCTGAGGA-3 and 5-ACGGTTAG-CTGCCCTAGGTATGAA-3
Protein fragments targeting PAR complex interactions.
To test the role of the PAR complex, the interactions between PAR3, PAR6 and aPKC were disrupted by overexpressing well-characterized fragments that can interfere with complex formation: the PAR3-PAR6 interaction was disrupted using amino acids 246-363 of PAR3 (ref. 18) , the PAR3-aPKC interaction was targeted using amino acids 712-946 of PAR3 (ref. 18, 27) and PAR6-aPKC binding was disrupted by amino acids 1-125 of PAR6 (ref. 27) . To further examine the role of aPKC in induced axonal outgrowth, we examined the effect of overexpressing aPKCζ KD, a kinasedead mutant (aPKCζ with the point mutation K273E) 39 . The fragments were overexpressed using a modified, non-toxic Sindbis pseudovirus variant containing an internal ribosome entry site that results in expression in more than 75% of all axons ( Supplementary Information, Fig. S1b ), as has been observed with this virus previously 29 . s u p p l e m e n ta r y i n f o r m at i o n www.nature.com/naturecellbiology 1 DOI: 10.1038/ncb1916 Figure S1 (a) Dose-response curve for axon outgrowth in response to NGF. Specific activities of NGF from different commercial suppliers varies greatly: according to the manufacturers' product sheets, the ED 50 of R&D NGF is 0.6-3 ng ml-1 while Invitrogen lists 5-100 ng ml -1 as the optimal dose for neurite growth on neurite on chick embryo DRG. To determine the optimal concentrations of the NGF used in this study (Invitrogen) for maximal axon outgrowth and to support survival without inducing axon outgrowth, we cultured dissociated E14 DRG neurons in microfluidic chambers. Axons were kept for 24 h in 0 ng ml -1 NGF before stimulation with different concentrations of NGF 
Figure S6
Influence of axonal PAR3 mRNA knockdown on axonal PAR3 and PAR6 protein levels and GSK3β phosphorylation. E14 DRG neurons were cultured in compartmentalized chambers. 24 h before the experiment siRNAs were selectively transfected in the axonal compartment and the axons were kept in 5 ng ml -1 NGF. (a) Axons were stimulated for 1 h with 100 ng ml -1 NGF and an immunostaining against PAR3 and tau-1 was performed. Application of NGF to axons leads to an increased PAR3 staining in control siRNA-but not PAR3 siRNA-transfected axons. The quantification for this data is presented in Fig. 5e . (b-d) 24 h after siRNA transfection axons were stimulated with 100 ng ml -1 NGF for 15 min, and an immunostaining against PAR6 and tau-1 (b) or phosphoGSK3β(Ser9) and GSK3β (d) was performed. (b) NGF stimulation leads to an increased PAR6 staining within growth cones, especially in filopodia. Knockdown of axonal PAR3 mRNA by siRNA does not change PAR6 localization. (c) Quantification of the results in (b). Images were thresholded using both the tau-1 and PAR6 staining to determine the three-dimensional boundaries of the growth cones in a z-stack of images. Average PAR6 pixel intensity was measured within the growth cones. One-way ANOVA with Bonferroni's post-test, ***P<0.001, n = 15 to 20 growth cones from three independent experiments. (d) Stimulation of axons with NGF leads to an increase of GSK3β(Ser9) phosphorylation as measured by the ratio of phosphoGSK3β(Ser9) over total GSK3β. siRNA-mediated knockdown of axonal PAR3 mRNA greatly reduces the NGF-dependent phosphorylation of GSK3β supporting the possibility that PAR3 translation induces GSK3β(Ser9) phosphorylation by a yet unknown mechanism. Scale bar, 20 µm. (e) Quantification of the results in (d). One-way ANOVA with Bonferroni's post-test, ***P<0.001, n = 28 to 36 growth cones from three independent experiments. (f) Specificity of the anti-phosphoGSK3β(Ser9) antibody. Incubation of HEK293 cells with calyculin A (100 nM), a serine/ threonine phosphatase inhibitor that is known to increase Ser9 phosphorylation on GSK3β 3 , greatly increases the intensity of the phosphoGSK3β(Ser9) staining without affecting total GSK3β staining. Treatment of the fixed cells with lambda protein phosphatase before the immunostaining reduced staining levels for phosphoGSK3β to background levels. One-way ANOVA with Dunnett's posttest, ***P<0.001, *P<0.05, n = 8 to 10 cells per condition. Scale bar, 20 µm. 
